Carregant...
Anlotinib-induced acute myocardial infarction: A case report and literature review
Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor, which has been recently approved for the treatment of advanced non-small cell lung cancer in China. One of its mechanisms of action is the inhibition of angiogenesis and it is similar to other anti-angiogenesis drugs, as it has car...
Guardat en:
| Publicat a: | Exp Ther Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444427/ https://ncbi.nlm.nih.gov/pubmed/32855689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9041 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|